It is India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).
Key Attributes
COVAXIN® is included along with immune-potentiators, also known as vaccine adjuvants, which are added to the vaccine to increase and boost its immunogenicity.
It is a 2-dose vaccination regimen.
It is a vaccine with no sub-zero storage, no reconstitution requirement, and ready to use liquid presentation in multi-dose vials, stable at 2-8oC.
The vaccine is developed using ‘Whole-Virion Inactivated Vero Cell’ derived platform technology. Inactivated vaccines do not replicate and are therefore unlikely to ....
